EVOQ Nano is a nanoscience company that engineers novel nanoparticles for the life science, materials science, and textile science industries. The company's multi-patented, high-volume laser nanofabrication process creates uniform, stable, sub-10nm nanoparticles with distinct surface chemistry suitable for a wide range of applications. EVOQ Nano is currently focused on developing nanoparticles for 3 core industries: EVOQ Bio has pioneered a nanomedicine platform with demonstrated antimicrobial efficacy against the worlds worst superbugs. In partnership with the Cystic Fibrosis Foundation, the company has developed a lead therapeutic. The FDA Pre-IND meeting is anticipated for 2024. EVOQ MedTech offers a breakthrough nanotechnology platform that integrates antimicrobial capabilities into medical devices to defend against a broad spectrum of contaminants like bacteria and fungi. The company has partnered with seven of the top catheter manufacturers with the aim of curbing hospital-acquired infections (HAIs). FUZE Technologies is an antimicrobial solutions company serving the textile, hospitality, fitness, and workspace industries. Its EPA-approved antimicrobial technology is free of chemicals, toxicity, and environmental waste. The company has secured contracts with some of the worlds most notable brands, including Nike, Adidas, the New England Patriots, Marriott, and Hilton.